bioRxiv Science⌕ Search

Biology subjects

Palm, F.

Publications and source records attributed to Palm, F..

2 recordsLinked to original sources

Temporal changes in platelet activation and organ dysfunction during invasive Streptococcus pyogenes infection

A key feature of sepsis is immune dysregulation caused when a local infection progresses to systemic disease. Innate immune cells, including platelets, can both contribute to immune defense but also to collateral organ damage. In this study, we characterized the molecular, cellular, and proteome responses at distinct stages of invasive Streptococcus pyogenes infection in a mouse model, from a local infection to dissemination and systemic inflammation. Invasion of bacteria to the bloodstream was associated with escalating cytokine levels, platelet activation, and an early leukocytosis that progressed to leukopenia. Multiparameter mapping of organ function using plasma biomarkers, histopathological changes, and proteome reorganization revealed distinct temporal patterns of organ dysfunction. Platelets were mobilized to the local skin infection at early stages of inflammation but also accumulated in the liver at later stages, coinciding with sepsis-induced organ damage. We demonstrated that S. pyogenes bound to the GPIb receptor on platelets in vitro, suggesting that bacteria may bind to platelets in the bloodstream. Treatment of infected mice with antibiotics diminished the bacterial load, reduced sepsis-induced organ damage, and partially reverted the disease-associated proteome rearrangement in the plasma and liver. Treatment of infected mice with pharmacological blockade of platelet activation with ticagrelor neither exacerbated disease nor significantly protected against sepsis-induced organ damage. However, at the proteome level, ticagrelor significantly reverted sepsis-induced platelet activation and stress responses in the liver. We conclude that platelets contribute to liver dysfunction in sepsis and may represent a target for adjunct therapy in combination with antibiotics.

microbiology↗

Repression of Hypoxia-Inducible Factor-1 Contributes to Increased Mitochondrial Reactive Oxygen Species Production in Diabetes

BackgroundExcessive production of mitochondrial reactive oxygen species (ROS) is a central mechanism for the development of diabetes complications. Recently, hypoxia has been identified to play an additional pathogenic role in diabetes. In this study, we hypothesized that ROS overproduction was secondary to the impaired responses to hypoxia due to the inhibition of hypoxia-inducible factor-1 (HIF-1) by hyperglycemia. MethodsThe dynamic of ROS levels was analysed in the blood of healthy subjects and individuals with type 1 diabetes after exposure to hypoxia (ClinicalTrials.gov registration no. NCT02629406). The relation between HIF-1, glucose levels, ROS production and its functional consequences were analyzed in renal mIMCD-3 cells and in kidneys of mouse models of diabetes. ResultsExposure to hypoxia increased circulating ROS in subjects with diabetes, but not in subjects without diabetes. High glucose concentrations repressed HIF-1 both in hypoxic cells and in kidneys of animals with diabetes, through a HIF prolyl-hydroxylase (PHD) - dependent mechanism. The impaired HIF-1 signaling contributed to excess production of mitochondrial ROS through increased mitochondrial respiration that was mediated by Pyruvate dehydrogenase kinase 1 (PDK1) and was followed by functional consequences. The restoration of HIF-1 function attenuated ROS overproduction despite persistent hyperglycemia, and conferred protection against apoptosis and renal injury in diabetes. ConclusionsWe conclude that the repression of HIF-1 plays a central role in mitochondrial ROS overproduction in diabetes and is a potential therapeutic target for diabetic complications. These findings are highly significant and timely since the first PHD inhibitor that can activate HIF-1 has been newly approved for clinical use.

cell biology↗